Clinical trial
A Post Market Surveillance on INFUSE Bone Graft
NCT05299762 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post Market Surveillance on INFUSE Bone Graft
- Lead sponsor
- Medtronic Spinal and Biologics
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 10, 2022
- Completion date
- August 31, 2025
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intervertebral disc degeneration, lumbar disc disease, spinal fusion